Listerial myocarditis as a complication of Listerial meningoencephalitis
Publication date: June 2018Source: Cor et Vasa, Volume 60, Issue 3Author(s): M. Strnadel, T. Hnátek, R. Havlíček, E. Krčová, M. Malý, M. ZavoralAbstractHere, we present a case report of a 53-year-old patient who was admitted for an acute ischaemic stroke. During the hospitalization period, the patient developed meningoencephalitis and acute myocarditis with recurrent episodes of ventricular fibrillation that required defibrillation repeatedly. Listeria monocytogenes was isolated from blood culture samples. The patient was treated with antibiotic therapy and showed a good clinical response. The diagnosis of myocarditi...
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Composite venous allograft for femoro-pedal bypass grafting in critical limb ischaemia
ConclusionMidterm patency of the reconstruction may be satisfactory provided that the ABO compatibility, short cold ischaemia time of the graft, adequate immunosuppressive therapy and proper follow-up protocol of the patient after vascular allograft transplantation are observed. Surgeons should keep in mind possibility of this technique mainly in diabetic patients with critical limb ischaemia and occluded crural vessels. (Source: Cor et Vasa)
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Takotsubo cardiomyopathy in a patient with essential thrombocythemia treated with anagrelide: Case report
We reported rare case of takotsubo cardiomyopathy caused by high dose anagrelide therapy. Anagrelide is the most often used in patients with thrombocythemia. It belongs to phosphodiesterase III inhibitors and through specific pathways has certain effects on myocardium. It is the first case of takotsubo cardiomyopathy resulting from anagrelide therapy in the Czech Republic. (Source: Cor et Vasa)
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Editorial Board
Publication date: June 2018Source: Cor et Vasa, Volume 60, Issue 3Author(s): (Source: Cor et Vasa)
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Transition from angiotensin-converting enzyme inhibitor/angiotensin-II-receptor-blocker to sacubitril/valsartan in chronic heart failure patients: Initial experiences in clinical practice
ConclusionThe transition from ACEi/ARB to S/V therapy appears to be safe and leads to an improvement in exercise tolerance and quality of life. (Source: Cor et Vasa)
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Increased dose of diuretics correlates with severity of heart failure and renal dysfunction and does not lead to reduction of mortality and rehospitalizations due to acute decompensation of heart failure; data from AHEAD registry
ConclusionThe dose of a loop diuretic recommended to patients with acute heart failure at hospital discharge correlates well with the severity of heart failure. When comparing the groups of patients with a higher dose of furosemide (41–125 mg) and a lower dose of furosemide (10–40 mg) we found that after adjustment using propensity score matching the higher dose of loop diuretic had a neutral effect on the incidence of the composite endpoint of overall mortality and/or readmission for ADHF. (Source: Cor et Vasa)
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Chronic heart failure – Impact of the condition on patients and the healthcare system in the Czech Republic: A retrospective cost-of-illness analysis
ConclusionThe data from clinical practice confirm that patients with chronic HF discharged from acute heart failure hospitalization are at high risk of death and/or subsequent hospitalization. The average annual costs for all-cause hospitalizations of CHS patients within the first and second years are CZK 58,528 and CZK 23,082 per patient, respectively. The costs attributed to all-cause hospitalization care of chronic HF patients can be estimated as approximately 7.7% of all annual inpatient expenses of health insurance companies and 2.7% of total healthcare expenditures in the Czech Republic. (Source: Cor et Vasa)
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Cardiac arrest center – One-year experience of the Regional Hospital Liberec
ConclusionCentralization of post cardiac arrest care using previously established infrastructure is feasible in our region. Furthermore, it resulted in the increase of directly transported patients and led to the increase of the total number of patients admitted without increasing the proportion of patients with a non-cardiac cause of OHCA. There was no significant change in mortality and neurological outcome. (Source: Cor et Vasa)
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Analysis of time intervals related to STEMI management in 2008–2016
ConclusionThe time intervals do not vary among individual years (with some exceptions). The route of transportation, which is a patient's choice, on the total ischaemic time is however a crucial and predominant factor affecting the total ischaemic time as well as individual intervals. (Source: Cor et Vasa)
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Low cardiovascular event rate and high atrial fibrillation recurrence rate one year after electrical cardioversion
ConclusionsCardiovascular event rate one year after electrical cardioversion was low. Electrical cardioversion had a high immediate success rate, however, maintenance of stable sinus rhythm in the long term was low. (Source: Cor et Vasa)
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Large vessel vasculitis
Publication date: June 2018Source: Cor et Vasa, Volume 60, Issue 3Author(s): Lucie Zavadilová, Ladislav GergelyAbstractVasculitis represents a heterogeneous group of immunopathological diseases, characterized by the inflammation of blood vessels leading to destruction of the vascular wall, subsequent proliferation and constriction, or even blockage of the lumen. According to their range, inflammatory changes cause various severe systemic manifestations such as loss of appetite, weight loss, fever of unknown origin, and night sweats; locally causing ischemia of areas supplied by the affected artery. The aim of our paper is...
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Heart failure and inhibition of renin–angiotensin–aldosterone system
Publication date: June 2018Source: Cor et Vasa, Volume 60, Issue 3Author(s): Jiří Vítovec, Jindřich Špinar, Lenka ŠpinarováAbstractA historical survey is presented of mortality clinical trials focussed on the inhibition of the renin–angiotensin–aldosterone system on different levels in patients with chronic heart failure. The first study, CONSENSUS, was published in 1987 and showed that the ACE-inhibitor enalapril clearly reduced mortality in severe heart failure compared with placebo. This was followed by studies with beta blockers, angiotensin II type 1 receptor blockers, blockers of mineralocorticoid receptor...
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Obstructive sleep apnea in outpatient care – What to do with?
Publication date: June 2018Source: Cor et Vasa, Volume 60, Issue 3Author(s): Monika Kamasová, Jan Václavík, Eva Kociánová, Miloš TáborskýAbstractObstructive sleep apnea is a relatively common sleep disorder, which is on the increase in the last decades. It significantly contributes to morbidity and mortality in all countries worldwide. Obstructive sleep apnea is one of the most common causes of daytime sleepiness. Typical risk factors for obstructive sleep apnea in the normal adult population are male gender, obesity (preferentially central obesity), and increased neck circumference, presence of manifest cardiovasc...
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Asymptomatic damage of central nervous system defined by excess level of protein S100B by patients undergoing the radiofrequency ablation of ventricular tachycardia
ConclusionThe elevation of the S100B protein after catheter ablation for ventricular arrhythmias is relatively common in our set. We did not identify any macroscopic changes on CT of CNS even by neurological examination.The level of renal insufficiency, the progression of cardiac failure, and the use of inhaled anesthesia with sevoflurane correlate with the amount of S100B as the biomarker of asymptomatic disability of CNS by patients receiving radiofrequency catheter ablation for ventricular arrhythmias. (Source: Cor et Vasa)
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
Echocardiography in patients with chronic kidney diseases
Publication date: June 2018Source: Cor et Vasa, Volume 60, Issue 3Author(s): Jan Malík, Vilém Danzig, Vladimíra Bednářová, Zdenka HruškováAbstractVast majority of chronic kidney disease patients die from cardiovascular complications. Echocardiography is a fundamental method, which reveals many of them. They include especially dilatation and systolic dysfunction of the left ventricle and atrium, left ventricular hypertrophy, diastolic dysfunction of the left ventricle, heart calcification, which could lead up to the development of stenotic valvular disease, right ventricular dysfunction and pulmonary hypertension. P...
Source: Cor et Vasa - July 5, 2018 Category: Cardiology Source Type: research
